RG60 Body Filler Launched by Genèse Labs France and Added to EG Bio’s Distribution Portfolio

A strategic body filler solution for the Middle East & CIS market

In October 2023, RG60 Body Filler was officially launched by Genèse Labs France and added to EG Bio Co., Ltd.’s distribution portfolio as part of its international expansion strategy. RG60 Body Filler was introduced as a strategic product designed to address market-specific requirements, with particular focus on the Middle East & CIS regions. Following its launch, EG Bio began supporting global distribution and market development through its established B2B network and regional partners.

The addition of RG60 to EG Bio’s portfolio reflects close cooperation between EG Bio and Genèse Labs France, ensuring clear brand positioning, structured market entry, and reliable supply for international partners.

Through this collaboration, EG Bio continues to strengthen its role as a trusted distribution partner for global aesthetic brands seeking targeted and sustainable market growth.

About Genèse Labs France

Genèse Labs France is a France-based company specializing in aesthetic and dermocosmetic products developed for professional markets. The company focuses on building structured product portfolios aligned with international market requirements, emphasizing quality standards, regulatory readiness, and long-term brand development. Genèse Labs France works with selected partners to support global distribution and sustainable market expansion.